BNP Paribas Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $89.5K | Buy |
321
+67
| +26% | +$19.3K | ﹤0.01% | 1541 |
|
|
2025
Q4 | $77K | Buy |
254
+73
| +40% | +$22.8K | ﹤0.01% | 1540 |
|
|
2025
Q3 | $51K | Sell |
181
-5
| -3% | -$1.36K | ﹤0.01% | 1049 |
|
|
2025
Q2 | $45K | Buy |
+186
| New | +$44K | ﹤0.01% | 1176 |
|
|
2025
Q1 | – | Sell |
-722
| Closed | -$237K | – | 872 |
|
|
2024
Q4 | $237K | Sell |
722
-81
| -10% | -$27.5K | ﹤0.01% | 881 |
|
|
2024
Q3 | $269K | Sell |
803
-933
| -54% | -$296K | ﹤0.01% | 859 |
|
|
2024
Q2 | $474K | Buy |
1,736
+795
| +84% | +$231K | ﹤0.01% | 881 |
|
|
2024
Q1 | $325K | Buy |
941
+124
| +15% | +$40.8K | ﹤0.01% | 840 |
|
|
2023
Q4 | $264K | Buy |
817
+101
| +14% | +$31.7K | ﹤0.01% | 819 |
|
|
2023
Q3 | $257K | Buy |
+716
| New | +$276K | ﹤0.01% | 823 |
|
|
2023
Q2 | – | Sell |
-440
| Closed | -$211K | – | 858 |
|
|
2023
Q1 | $211K | Sell |
440
-2,186
| -83% | -$1.02M | ﹤0.01% | 864 |
|
|
2022
Q4 | $1.1M | Buy |
2,626
+172
| +7% | +$69.4K | ﹤0.01% | 764 |
|
|
2022
Q3 | $1.02M | Buy |
2,454
+268
| +12% | +$134K | ﹤0.01% | 754 |
|
|
2022
Q2 | $1.08M | Sell |
2,186
-449
| -17% | -$234K | ﹤0.01% | 771 |
|
|
2022
Q1 | $1.48M | Buy |
+2,635
| New | +$1.59M | 0.01% | 691 |
|
|
2016
Q4 | – | Sell |
-3,806
| Closed | -$623K | – | 985 |
|
|
2016
Q3 | $623K | Hold |
3,806
| – | – | 0.01% | 912 |
|
|
2016
Q2 | $544K | Hold |
3,806
| – | – | ﹤0.01% | 949 |
|
|
2016
Q1 | $520K | Hold |
3,806
| – | – | ﹤0.01% | 937 |
|
|
2015
Q4 | $528K | Buy |
+3,806
| New | +$528K | ﹤0.01% | 917 |
|
Other funds holding BIO
VCM
VPM
AI
